Featuring new scientific work with internationally-known speakers, expert panels, early career investigators, and audience participation.
Seasoned business leader and researcher, Chris Spera, Ph.D, takes the helm at Arbor Research, succeeding retiring president, Robert M. Merion, M.D. FACS.
Using data from the United States Renal Data System (USRDS), our researchers calculated access procedure (intervention) rates in the US for patients starting hemodialysis with an AVF or AVG created during their first year of hemodialysis therapy between July 1, 2012 and December 31, 2014 (N = 73,027).
Dr. Robert M. Merion, MD, FACS has announced that he will step down as President and Chief Executive Officer of Arbor Research Collaborative for Health by August 2021.
